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Summary Relative survival rates in the National Cancer Institute (NCI) 'SEER' review of cancer in the USA are fitted by a model which can
be used to estimate median survival time in any calendar year. It is argued that median survival times (MSTs) are better indicators of survival
than 5-year relative survival rates (RSRs), especially when survival times are short.
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The SEER review of cancer statistics 1973-90 (Miller et al, 1993)
contains organ-specific survival tables for selected regions of the
USA. These tables show relative survival rates (RSR) by calendar
year, that is, observed survival rates adjusted for expected
mortality using total US age-, sex- and race-specific rates for each
year (Ederer et al, 1961).
We have found that the survival tables can be fitted by the
equation:
RSR=Z+(100-Z)exp {- (A+BT)t}
where T is the calendar time from 1 to 18 (1973 = 1) and t is the
survival time from I to 17 years. RSR is 100% at t =0 andA, B and
Z are constants obtained from the fit. According to this equation,
RSR decreases exponentially with survival time t in any given
calendar year T(columns ofthe table) and the exponential factor is
linear with T for constant t (rows of the table). The mean 5-year
RSR is obtained by solving the equation for t = 5 and averaging for
as many values of T as required. This can be compared with the
mean RSR taken directly from table entries (T= 1-13). The median
survival time (MST) can also be obtained from the equation by
setting RSR = 50% and solving the equation for any specified T.
This cannot be done precisely from table entries because they are
tabulated by year ofsurvival and not by RSR. The median survival
time (which is the same as the half-life) may extend outside the
range oftable values, in which case it is necessary to use alternative
indicators such as the upper quartile survival time.
METHODS
The tables were fitted using an iteratively reweighted least-squares
procedure (NAG, 1995), the observed values being weighted
inversely to the squares ofthe calculated values in the usual expec-
tation that errors of observation are proportional to the expected
values.
The mean value of the 5-year RSR was obtained in the usual
way by taking the mean of the t = 5 row of the survival table. An
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estimate ofthe 5-year RSR can also be obtained from the modelby
setting t = 5 and solving the equation for RSR for values ofTfrom
1 to 18. The mean value thus obtained from the model has the
advantage of being obtained from the fitted values to all
the entries in the table, and not just the fifth row. A comparison
between the two, however, provides a useful check on the model,
as shown in Table 1.
The median survival time for each column ofthe survival table,
that is, each calendar year, can be obtained by setting T to the
required value, RSR to 50% and solving the equation for t, which
is now the median survival time. At values ofZ> 50%, however,
the value oftis indeterminate, butby setting RSR = 75% the upper
quartile survival time can be obtained. In a few cases, the upper
quartile survival time is also indeterminate, although decile
survival times could be used ifnecessary.
RESULTS
Table 1 shows the results forthe 24 sites from the 'SEER' survival
tables (Miller et al, 1993). The data are for both sexes and all
races, except for sex-specific sites. The degree of fit was mostly
good. Table 1 is arranged in order of increasing Z because this is
the parameter which necessitates the change from median survival
time to upper quartile survival time. There is good agreement
between the mean 5-year RSRs from the 5th row of the survival
tables and those derived from the model. The survival rates for all
cancers except those for oral cavity and cervix uteri show an
improvement with calendar time. The improvement for prostate is
especially good, although it remains to be shown whether this is
related to therapy. There are two types of termination of the
survival table at large survival times t. Inspection of the tables
shows that they either terminate in constant values at large t,
suggestive of a 'background', or they terminate at some point
during the exponential decay as discussed below.
DISCUSSION
The median survival time forany column in the survival tablecanbe
obtained by interpolating within or extrapolating from that column,
without the use of a fitted model. Further, because the median, like
the relative survival rate, is a non-parametric statistic, the value
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Table 1
Mean Mean Upper
RSR (5 year) RSR Median survival quartile survival
from from 5th time (years) time (years)
model row of
R2 (fit) Z (%) (%) table 1973 1990 1973 1990
Pancreas 0.564 2.6 2.7 2.9 0.43 0.52 - -
Liver 0.403 3.6 4.1 4.0 0.38 0.97 -
Oesophagus 0.691 3.8 6.1 6.0 0.64 1.42 -
Multiple myeloma 0.980 5.9 27.0 26.1 2.30 2.80 -
Lung 0.790 10.4 11.3 12.9 0.83 0.98 -
Stomach 0.818 14.2 15.3 16.4 0.85 1.17 -
Brain and ONS 0.710 20.1 22.1 23.8 1.02 1.71 -
Leukaemias 0.866 21.7 35.2 36.1 2.67 3.16 -
Prostate 0.976 31.9 75.9 70.6 9.23 36.23 -
Non-Hodgkin's lymphoma 0.895 33.2 49.3 49.3 3.87 6.23 -
Ovary 0.948 34.1 37.8 38.3 1.92 3.13 -
Oral cavity and pharynx 0.934 38.7 51.1 52.5 5.52 5.07 -
Colorectal 0.947 45.2 53.6 52.6 4.19 10.68 -
Kidney and renal pelvis 0.774 45.2 49.9 51.8 3.89 6.32 -
Larynx 0.883 46.4 67.3 66.3 13.00 15.95 -
Breast (50 and over) 0.992 46.6 76.8 75.1 - - 4.37 7.43
Breast (<50 years) 0.985 50.1 77.7 76.2 - - 5.21 6.73
Hodgkin's lymphoma 0.862 56.2 75.7 73.2 - - 3.26 10.68
Cervix uteri 0.925 61.9 66.5 67.5 - - 2.67 2.39
Urinary bladder 0.911 63.8 76.6 75.4 - - 3.77 9.74
Melanoma of skin 0.907 67.9 83.9 80.9 - - 6.57 23.93
Testis 0.760 71.1 93.5 86.1 - - 9.89 ND
Corpus uteri, NOS 0.611 84.3 85.1 84.4 - - ND ND
Thyroid 0.408 91.9 92.6 92.8 - - ND ND
ND, Not a determinate number; ONS, other nervous systems; NOS, not otherwise specified.
obtained does not depend on the distribution ofdata in the column.
This piecemeal approach to analysis, however, could be misleading
because columns with the same MSTs could have widely differing
distributions. The fitting ofa model averages the deviations over all
the data and fits the same function to all the columns.
A surprising feature of this work is that these cancer survival
tables show exponential survival curves. It is well known that an
exponential decay occurs when each member of a population has
an equal and constant probability of survival. This cannot be said
ofthe cancer patient; it is well known that appropriate therapy can
often extend the patient's life. If, however, the patients in any one
year receive therapy which extends theirprobability ofsurvival by
a constant factor, then the survival curve in that particular column
of the table will still be exponential. This is the simplest explana-
tion for the exponential distribution ofthe data.
The median survival time can often be a more useful indicator
than the frequently used 5-year relative survival rate. When
survival times are short, the RSR can be a meaningless zero. The
first three entries in Table 1 would show this effect except that the
exponential decay descends to a constant value ofzero slope. Like
a radioactive decay, this suggests a 'background' indicative oftwo
populations, one constant and the other decaying with time.
Possible reasons are that a proportion ofthe patients were misdiag-
nosed as having cancer, or that a proportion of those diagnosed
were cured or that they had a spontaneous regression. It is possible
that the survival tables for other cancer sites will eventually
exhibit this characteristic.
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For 'kidney and renal pelvis', the table contains data on two
different kinds of cancer (Kosary and Mclaughlin, 1993). Renal
cell cancers are mostly adenocarcinomas ofthe body ofthe kidney,
in contrast to renal pelvis cancers that are mostly transitional cell
carcinomas. Ifthe data for these two cancers each follow an expo-
nential distribution, but with different time constants, then the
combination of both sets of data is not itself distributed exponen-
tially. The fact that a fit was obtained for the combined set
indicates that the rate constants are not substantially different. A
separate analysis ofeach set ofdata (ifavailable) would, however,
give a better fit to an exponential distribution.
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